NCT01451203View on ClinicalTrials.gov

Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

October 11, 2011

Primary Completion Date

August 28, 2013

Study Completion Date

October 20, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Placebo

Subcutaneous (SC)

DRUG

CZP

SC

DRUG

methotrexate (MTX)

oral

Trial Locations (8)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
collaborator

UCB Japan Co. Ltd.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY